Has Rachit Vakil, MD received payments from drug or device companies?

Yes. Drug and device makers reported $29,839 in general payments to Rachit Vakil, MD across 102 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Rachit Vakil, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Rachit Vakil, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Rachit Vakil, MD

Cardiovascular Disease · Moorestown, NJNPI 1356705180

Payments from drug & device makers

$29,839in general payments, 2019–2025

Across 102 payments — averaging $292.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$23K
Medtronic$3K
Biotronik Inc.$1K
Abbott$951
Biosense Webster, Inc.$759
Cardiva Medical, Inc.$244
plus $33 from 2 others

What the payments were for

Grants$21,50072%
Travel & lodging$3,75913%
Food & beverage$4,04714%
Education$5322%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	27	$23,467
Medtronic	15	$3,168
Biotronik Inc.	7	$1,216
Abbott	15	$951
Biosense Webster, Inc.	34	$759
Cardiva Medical, Inc.	2	$244
Philips North America LLC	1	$19
Johnson & Johnson	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,839 in reported general payments places this provider in the 90th percentile of 1,006 cardiovascular disease providers in New Jersey.

See all cardiovascular disease providers in New Jersey →

Medicare billing

Part B allowed, 2024

$31,348

Medicare patients

Services billed

211

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$13,451

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Moorestown

Robert KippermanMorristown$5.3M
Sharan MahalBridgewater$3.5M
Linda GillamMorristown$2.2M
Mark GelerntHaddon Heights$2M
Robert FishbergSpringfield$1.9M
Dilip ViswanathHaddon Heights$1.8M
Marc CohenNewark$1M
Jasjit WaliaElizabeth$859K
Sajjad SabirCamden$742K
John CovaleskyManalapan$716K

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →